Current Psychiatry Reports

, Volume 7, Issue 3, pp 168–179 | Cite as

Visual hallucinations and the charles bonnet syndrome

  • Dominic H. Ffytche

Abstract

After dividing clinicians for almost 70 years, Charles Bonnet syndrome has reached an impasse. Defined by a neurologist in the 1930s, the syndrome was intended to eponymize the association of visual hallucinations with age, but evolved into one describing their association with eye disease or, more recently, an etiologically neutral phenomenologic description. Each tradition has its merits but none has defined a specific clinical entity or accounted for visual hallucinations across the spectrum of associated clinical conditions. Recent insights into the neurobiology of vision have shed new light on the problem. Viewed from a neuro-phenomenologic perspective, clinical evidence reveals two distinct hallucination syndromes: one directly related to visual system pathology, the other to pathology in the brainstem or ascending neurotransmitter pathways. The implication is of two independent but interacting pathophysiologic mechanisms and of a need to reassess the classification and management of this common psychopathologic symptom.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Flournoy T: Le Cas de Charles Bonnet: hallucinations visuelles chez un vieillard opèrè de la cataracte. Arch Psychol (Geneva) 1902, 1:1–23.Google Scholar
  2. 2.
    Clarke E, Jacyna LS: Nineteenth-century Origins of Neuroscience Concepts. Berkeley: University of California Press; 1987.Google Scholar
  3. 3.
    de Morsier G: Les automatismes visuels. (Hallucinations visuelles rètrochiasmatiques). Schweizerische Medizinische Wochenschrift 1936, 66:700–703.Google Scholar
  4. 4.
    de Morsier G: Le syndrome de Charles Bonnet: hallucinations visuelles des vieillards sans deficience mentale. Ann Med Psychol (Paris) 1967, 125:677–702. This is the history of the Charles Bonnet syndrome from the perspective of its founding father.Google Scholar
  5. 5.
    Lhermitte J: Les hallucinations: clinique et physiopathologie Paris: G Doin; 1951.Google Scholar
  6. 6.
    Burgermeister JJ, Tissot R, de Ajuriaguerra J: Les hallucinations visuelles des ophthalmopathes. Neuropsychologia 1965, 3:9–38.CrossRefGoogle Scholar
  7. 7.
    de Morsier G: [Diencephalic visual hallucinations. II] Psychiatr Clin (Basel) 1969, 2:232–251.Google Scholar
  8. 8.
    Uhthoff W: Beiträge zu den Gesichtstäuschungen (Hallucinationen, Illusionen etc.) bei Erkrankungen des Sehorgans. Monatsschrift Psychiat Neurol 1899, 5:241–379.CrossRefGoogle Scholar
  9. 9.
    Lhermitte J, De Ajuriaguerra J: Hallucinations visuelles et lèsions de l’appareil visuel. Ann Med Psychol (Paris) 1936, 94:321–351.Google Scholar
  10. 10.
    Hecaen H, Garcia Badaracco J: Les hallucinations visuelles au cours des ophthalmopathies et des lesions des nerfs et du chiasma optiques. L’Evolution Psychiat 1956, 157–179.Google Scholar
  11. 11.
    Hecaen H, Le Guen C: Hallucinations visuelles chez un ophthalmopathe (syndrome de Charles Bonnet). Ann Med Psychol (Paris) 1960, 118:152–156.Google Scholar
  12. 12.
    Müller J: Über die phantastischen Gesichtserscheinungen. Coblenz: Jacob Hölscher; 1826.Google Scholar
  13. 13.
    Berrios GE, Brook P: The Charles Bonnet syndrome and the problem of visual perceptual disorders in the elderly. Age Aging 1982, 11:17–23.CrossRefGoogle Scholar
  14. 14.
    Damas-Mora J, Skelton-Robinson M, Jenner FA: The Charles Bonnet Syndrome in perspective. Psychol Med 1982, 12:251–261.PubMedCrossRefGoogle Scholar
  15. 15.
    Gold K, Rabins PV: Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation of six cases. Comp Psychiatry 1989, 30:90–98. The Charles Bonnet Syndrome as defined by psychiatry.CrossRefGoogle Scholar
  16. 16.
    ffytche DH, Catani M: Beyond localisation: from hodology to function. Phil Trans R Soc Lond B 2005, In press.Google Scholar
  17. 17.
    Kanwisher N, McDermott J, Chun MM: The fusiform face area: a module in human extrastriate cortex specialized for face perception. J Neurosci 1997, 17:4302–4311.PubMedGoogle Scholar
  18. 18.
    Zeki S, Watson JDG, Lueck CJ, et al.: A direct demonstration of functional specialization in human visual cortex. J Neurosci 1991, 11:641–649.PubMedGoogle Scholar
  19. 19.
    Epstein R, Kanwisher N: A cortical representation of the local visual environment. Nature 1998, 392:598–601.PubMedCrossRefGoogle Scholar
  20. 20.
    Ishai A, Ungerleider LG, Martin A, et al.: Distributed representation of objects in the human ventral visual pathway. Proc Natl Acad Sci U S A 1999, 96:9379–9384.PubMedCrossRefGoogle Scholar
  21. 21.
    Cohen L, Dehaene S, Naccache L, et al.: The visual word form area. Spatial and temporal characterisation of an initial stage of reading in normal subjects and posterior split-brain patients. Brain 2000, 123:291–307.PubMedCrossRefGoogle Scholar
  22. 22.
    Puce A, Allison T, Asgari M, et al.: Differential sensitivity of human visual cortex to faces, letterstrings, and textures: a functional magnetic resonance imaging study. J Neurosci 1996, 16:5205–5215.PubMedGoogle Scholar
  23. 23.
    Watson JDG, Myers R, Frackowiak RSJ, et al.: Area V5 of the human brain: evidence from a combined study using positron emission tomography and magnetic resonance imaging. Cereb Cortex 1993, 3:79–94.PubMedCrossRefGoogle Scholar
  24. 24.
    Downing PE, Jiang Y, Shuman M, Kanwisher N: A cortical area selective for visual processing of the human body. Science 2001, 293:2470–2473.PubMedCrossRefGoogle Scholar
  25. 25.
    Malach R, Reppas JB, Benson RR, et al.: Object-related activity revealed by functional magnetic resonance imaging in human occipital cortex. Proc Natl Acad Sci U S A 1995, 92:8135–8139.PubMedCrossRefGoogle Scholar
  26. 26.
    Puce A, Allison T, Bentin S, et al.: Temporal cortex activation in humans viewing eye and mouth movements. J Neurosci 1998, 18:2188–2199.PubMedGoogle Scholar
  27. 27.
    Tootell RB, Hadjikhani NK, Vanduffel W, et al.: Functional analysis of primary visual cortex (V1) in humans. Proc Natl Acad Sci U S A 1998, 95:811–817.PubMedCrossRefGoogle Scholar
  28. 28.
    Zeki S, Ffytche DH: The Riddoch syndrome: insights into the neurobiology of conscious vision. Brain 1998, 121:25–45.PubMedCrossRefGoogle Scholar
  29. 29.
    Moutoussis K, Zeki S: The relationship between cortical activation and perception investigated with invisible stimuli. Proc Natl Acad Sci U S A 2002, 99:9527–9532.PubMedCrossRefGoogle Scholar
  30. 30.
    Pins D, Ffytche DH: The neural correlates of conscious vision. Cereb Cortex 2003, 13:461–474.PubMedCrossRefGoogle Scholar
  31. 31.
    Block N: Two neural correlates of consciousness. Trends Cogn Sci 2005, 9:46–52.PubMedCrossRefGoogle Scholar
  32. 32.
    Ffytche DH, Howard RJ, Brammer MJ, et al.: The anatomy of conscious vision: an fMRI study of visual hallucinations. Nature Neurosci 1998, 1:738–742. This is the only study to date to capture visual hallucinations as they occur in the scanner.PubMedCrossRefGoogle Scholar
  33. 33.
    Silbersweig DA, Stern E, Frith CD, et al.: A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995, 378:176–179.PubMedCrossRefGoogle Scholar
  34. 34.
    Wunderlich G, Suchan B, Volkmann J, et al.: Visual hallucinations in recovery from cortical blindness: imaging correlates. Arch Neurol 2000, 57:561–565.PubMedCrossRefGoogle Scholar
  35. 35.
    Adachi N, Watanabe T, Matsuda H, Onuma T: Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in patients with Charles Bonnet syndrome. Psychiatry Clin Neurosci 2000, 54:157–162.PubMedCrossRefGoogle Scholar
  36. 36.
    Imamura T, Ishii K, Hirono N, et al.: Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport 1999, 10:1903–1907.PubMedCrossRefGoogle Scholar
  37. 37.
    Stebbins GT, Goetz CG, Carrillo MC, et al.: Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004, 63:1409–1416. This is the first study to use specific functional probes to look for changes in the visual response characteristics of hallucinator brains.PubMedGoogle Scholar
  38. 38.
    Nagano-Saito A, Washimi Y, Arahata Y, et al.: Visual hallucination in Parkinson’s disease with FDG PET. Mov Disord 2004, 19:801–806.PubMedCrossRefGoogle Scholar
  39. 39.
    Holroyd S, Shepherd ML, Downs III JH: Occipital atrophy is associated with visual hallucinations in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 2000, 12:25–28.PubMedGoogle Scholar
  40. 40.
    Ffytche DH, Howard RJ: The perceptual consequences of visual loss: positive pathologies of vision. Brain 1999, 122:1247–1260.PubMedCrossRefGoogle Scholar
  41. 41.
    Heo K, Cho YJ, Lee SK, et al.: Single-photon emission computed tomography in a patient with ictal metamorphopsia. Seizure 2004, 13:250–253.PubMedCrossRefGoogle Scholar
  42. 42.
    Zeki S, Watson JDG, Frackowiak RSJ: Going beyond the information given: the relation of illusory visual motion to brain activity. Proc R Soc Lond B 1993, 252:215–222.CrossRefGoogle Scholar
  43. 43.
    Ffytche DH, Zeki S: Brain activity related to the perception of illusory contours. Neuroimage 1996, 3:104–108.PubMedCrossRefGoogle Scholar
  44. 44.
    Tootell RBH, Reppas JB, Dale AM, et al.: Visual motion aftereffect in human cortical area MT revealed by functional magnetic resonance imaging. Nature 1995, 375:139–141.PubMedCrossRefGoogle Scholar
  45. 45.
    Nunn JA, Gregory LJ, Brammer M, et al.: Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words. Nat Neurosci 2002, 5:371–375.PubMedCrossRefGoogle Scholar
  46. 46.
    Braun AR, Balkin TJ, Wesenten NJ, et al.: Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 1997, 120 (Pt 7):1173–1197.PubMedCrossRefGoogle Scholar
  47. 47.
    Howard RJ, Ffytche DH, Barnes J, et al.: The functional anatomy of imagining and perceiving colour. Neuroreport 1998, 9:1019–1023.PubMedCrossRefGoogle Scholar
  48. 48.
    Kosslyn SM, Thompson WL: When is early visual cortex activated during visual mental imagery? Psychol Bull 2003, 129:723–746.PubMedCrossRefGoogle Scholar
  49. 49.
    Ganis G, Thompson WL, Kosslyn SM: Brain areas underlying visual mental imagery and visual perception: an fMRI study. Brain Res Cogn Brain Res 2004, 20:226–241.PubMedCrossRefGoogle Scholar
  50. 50.
    Mechelli A, Price CJ, Friston KJ, Ishai A: Where bottom-up meets top-down: neuronal interactions during perception and imagery. Cereb Cortex 2004, 14:1256–1265.PubMedCrossRefGoogle Scholar
  51. 51.
    Teunisse RJ, Cruysberg JR, Verbeek AL, Zitman FG: The Charles Bonnet syndrome: a large prospective study in the Netherlands. B J Psych 1995, 166:254–257. This study, in addition to Holroyd et al. [52] and Teunisse et al. [74], re-awakened interest in the Charles Bonnet Syndrome by revealing an unexpectedly high prevalence in ophthalmic populations.Google Scholar
  52. 52.
    Holroyd S, Rabins PV, Finkelstein D, et al.: Visual hallucinations in patients with macular degeneration. Am J Psych 1992, 149:1701–1706. See [51].Google Scholar
  53. 53.
    Scott IU, Schein OD, Feuer WJ, Folstein MF: Visual hallucinations in patients with retinal disease. Am J Ophthalmol 2001, 131:590–598.PubMedCrossRefGoogle Scholar
  54. 54.
    Tan CS, Lim VS, Ho DY, et al.: Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre. Br J Ophthalmol 2004, 88:1325–1329.PubMedCrossRefGoogle Scholar
  55. 55.
    Kölmel HW: Coloured patterns in hemianopic fields. Brain 1984, 107:155–167.PubMedCrossRefGoogle Scholar
  56. 56.
    Kölmel HW: Complex visual hallucinations in the hemianopic field. J Neurol, Neurosurg Psychiatry 1985, 48:29–38.CrossRefGoogle Scholar
  57. 57.
    Lepore FE: Spontaneous visual phenomena with visual loss. Neurology 1990, 40:444–447.PubMedGoogle Scholar
  58. 58.
    Vaphiades MS, Celesia GG, Brigell MG: Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology 1996, 47:408–417.PubMedGoogle Scholar
  59. 59.
    Sanchez-Ramos JR, Ortoll R, Paulson GW: Visual hallucinations associated with Parkinson disease. Arch Neurol 1996, 53:1265–1268.PubMedGoogle Scholar
  60. 60.
    Graham JM, Grünewald RA, Sagar HJ: Hallucinosis in idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1997, 63:424–440.Google Scholar
  61. 61.
    Diederich NJ, Pieri V, Goetz CG: [Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison]. Fortschr Neurol Psychiatr 2000, 68:129–136.PubMedCrossRefGoogle Scholar
  62. 62.
    Fènelon G, Mahieux F, Huon R, Ziègler M: Hallucinations in Parkinson’s disease: prevalence phenomenology and risk factors. Brain 2000, 123:733–745. This study is a detailed phenomenologic survey of hallucinations in Parkinson’s disease highlighting the frequent occurrence of extracampine hallucinations.PubMedCrossRefGoogle Scholar
  63. 63.
    Holroyd S, Currie L, Wooten GF: Prospective study of hallucinations and delusions in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2001, 70:734–738.PubMedCrossRefGoogle Scholar
  64. 64.
    Barnes J, David AS: Visual hallucinations in Parkinson’s disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001, 70:727–733.PubMedCrossRefGoogle Scholar
  65. 65.
    Ballard C, Holmes C, McKeith I, et al.: Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease. Am J Psychiatry 1999, 156:1039–1045.PubMedGoogle Scholar
  66. 66.
    Platz WE, Oberlaender FA, Seidel ML: The phenomenology of perceptual hallucinations in alcohol-induced delirium tremens. Psychopathology 1995, 28:247–255.PubMedCrossRefGoogle Scholar
  67. 67.
    Webster R, Holroyd S: Prevalence of psychotic symptoms in delirium. Psychosomatics 2000, 41:519–522.PubMedCrossRefGoogle Scholar
  68. 68.
    Bracha HS, Wolkowitz OM, Lohr JB, et al.: High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry 1989, 146:526–528.PubMedGoogle Scholar
  69. 69.
    Howard R, Levy R: Charles Bonnet syndrome plus: complex visual hallucinations of Charles Bonnet syndrome type in late paraphrenia. Int J Geriatr Psychiatry 1994, 9:399–404.CrossRefGoogle Scholar
  70. 70.
    Rees WD: The hallucinations of widowhood. BMJ 1971, 4:37–41.Google Scholar
  71. 71.
    Menon GJ, Rahman I, Menon SJ, Dutton GN: Complex visual hallucinations in the visually impaired: the Charles Bonnet Syndrome. Surv Ophthalmol 2003, 48:58–72. Comprehensive review of visual hallucinations in ophthalmic disease.PubMedCrossRefGoogle Scholar
  72. 72.
    Holroyd S, Rabins PV: A three year follow-up study of visual hallucinations in patients with macular degeneration. J Nerv Ment Dis 1996, 184:188–189.PubMedCrossRefGoogle Scholar
  73. 73.
    Schultz G, Needham W, Taylor R, et al.: Properties of complex hallucinations associated with deficits in vision. Perception 1996, 25:715–726.PubMedCrossRefGoogle Scholar
  74. 74.
    Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al.: Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet 1996, 347:794–797. See [51].PubMedCrossRefGoogle Scholar
  75. 75.
    Santhouse AM, Howard RJ, Ffytche DH: Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 2000, 123:2055–2064. Phenomenologic survey of ophthalmic visual hallucinations showing syndromic groupings of specific hallucination contents based on the anatomic proximity of the specialized cortical areas underlying them.PubMedCrossRefGoogle Scholar
  76. 76.
    Goetz CG, Stebbins GT: Risk factors for nursing home placement in advanced Parkinson’s disease. Neurology 1993, 43:2227–2229.PubMedGoogle Scholar
  77. 77.
    Goetz CG, Stebbins GT: Mortality and hallucinations in nursing home patients with advanced Parkinson’s disease. Neurology 1995, 45:669–671.PubMedGoogle Scholar
  78. 78.
    Goetz CG, Leurgans S, Pappert EJ, et al.: Prospective longitudinal assessment of hallucinations in Parkinson’s disease. Neurology 2001, 57:2078–2082.PubMedGoogle Scholar
  79. 79.
    Ballard C, McKeith I, Harrison R, et al.: A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer’s disease. Int Psychogeriatr 1997, 9:381–388. To date, the only phenomenologic survey of visual hallucinations to compare different clinical conditions within a single study.PubMedCrossRefGoogle Scholar
  80. 80.
    Gauntlett-Gilbert J, Kuipers E: Phenomenology of visual hallucinations in psychiatric conditions. J Nerv Ment Dis 2003, 191:203–205.PubMedCrossRefGoogle Scholar
  81. 81.
    Manford M, Andermann F: Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998, 121:1819–1840. A comprehensive review of visual hallucinations across a range of clinical contexts from a neurologic perspective. The authors put forward a unifying thalamic model.PubMedCrossRefGoogle Scholar
  82. 82.
    Mavromatis A: Hypnagogia. London: Routledge and Kegan Paul; 1987.Google Scholar
  83. 83.
    Panayiotopoulos CP: Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry 1999, 66:536–540.PubMedGoogle Scholar
  84. 84.
    Bien CG, Benninger FO, Urbach H, et al.: Localizing value of epileptic visual auras. Brain 2000, 123:244–253.PubMedCrossRefGoogle Scholar
  85. 85.
    Taylor I, Scheffer IE, Berkovic SF: Occipital epilepsies: identification of specific and newly recognized syndromes. Brain 2003, 126:753–769.PubMedCrossRefGoogle Scholar
  86. 86.
    Wilkinson F: Auras and other hallucinations: windows on the visual brain. Prog Brain Res 2004, 144:305–320.PubMedGoogle Scholar
  87. 87.
    Razavi M, Jones RD, Manzel K, et al.: Steroid-responsive charles bonnet syndrome in temporal arteritis. J Neuropsychiatry Clin Neurosci 2004, 16:505–508.PubMedGoogle Scholar
  88. 88.
    van Lommel P, van Wees R, Meyers V, Elfferich I: Near-death experience in survivors of cardiac arrest: a prospective study in the Netherlands. Lancet 2001, 358:2039–2045.PubMedCrossRefGoogle Scholar
  89. 89.
    Smythies JR: A preliminary analysis of stroboscopic patterns. Nature 1957, 179:523–524.CrossRefGoogle Scholar
  90. 90.
    Smythies JR: The stroboscopic patterns 2: The phenomenology of the bright phase and after images. Br J Psychol 1959, 50:305–324.PubMedGoogle Scholar
  91. 91.
    Smythies JR: The stroboscopic patterns 1: The dark phase. Br J Psychol 1959, 50:106–116.Google Scholar
  92. 92.
    Smythies JR: The stroboscopic patterns 3: Further experiments and discussion. Br J Psychol 1960, 51:247–255.Google Scholar
  93. 93.
    Ermentrout GB, Cowan JD: A mathematical theory of visual hallucination patterns. Biol Cybern 1979, 34:137–150.PubMedCrossRefGoogle Scholar
  94. 94.
    Bressloff PC, Cowan JD, Golubitsky M, et al.: Geometric visual hallucinations, Euclidean symmetry and the functional architecture of striate cortex. Phil Trans R Soc Lond B 2001, 356:299–330.CrossRefGoogle Scholar
  95. 95.
    ffytche DH, Pins D, Guy CN: The neural correlates of Purkinje patterns. In Washington DC: Society for Neuroscience. Abstract viewer/Itinery planner CD-ROM; 2002:Program no.260.15.Google Scholar
  96. 96.
    Merabet LB, Maguire D, Warde A, et al.: Visual hallucinations during prolonged blindfolding in sighted subjects. J Neuroophthalmol 2004, 24:109–113.PubMedGoogle Scholar
  97. 97.
    Lee HW, Hong SB, Seo DW, et al.: Mapping of functional organization in human visual cortex: electrical cortical stimulation. Neurology 2000, 54:849–854.PubMedGoogle Scholar
  98. 98.
    Chapman FM, Dickinson J, McKeith I, Ballard C: Associations among visual hallucinations, visual acuity and specific eye pathologies in Alzheimer’s disease. Am J Psych 1999, 156:1983–1985.Google Scholar
  99. 99.
    Diederich NJ, Goetz CG, Raman R, et al.: Poor visual discrimination and visual hallucinations in Parkinson’s disease. Clin Neuropharm 1998, 21:289–295.Google Scholar
  100. 100.
    Harding AJ, Broe GA, Halliday GM: Visual hallucinations in Lewy Body disease relate to Lewy bodies in the temporal lobe. Brain 2002, 125:391–403.PubMedCrossRefGoogle Scholar
  101. 101.
    Diederich NJ, Goetz CG, Stebbins GT: Repeated visual hallucinations in Parkinson’s disease as disturbed external/internal perceptions: Focused review and a new integrative model. Mov Disord 2005, 20:130–140. A comprehensive review of visual hallucinations in Parkinson’s disease. The authors integrate disparate experimental findings in a tridimensional model.PubMedCrossRefGoogle Scholar
  102. 102.
    Perry EK, Perry RH: Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995, 28:240–258. The cholinergic theory of visual hallucinations.PubMedCrossRefGoogle Scholar
  103. 103.
    Cogan DG: Visual hallucinations as release phenomena. Graefe’s Archiv Clin Exp Opthalmol 1973, 188:139–150. This study, together with [104], outlines the visual de-afferentation theory of visual hallucinations.CrossRefGoogle Scholar
  104. 104.
    Burke W: The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry 2002, 73:535–541. This article details the visual de-afferentation theory of visual hallucinations.PubMedCrossRefGoogle Scholar
  105. 105.
    Braun CM, Dumont M, Duval J, et al.: Brain modules of hallucination: an analysis of multiple patients with brain lesions. J Psychiatry Neurosci 2003, 28:432–449. A review of the lesion literature for visual, auditory, and somatosensory hallucinations deriving a modality-specific "release" model.PubMedGoogle Scholar
  106. 106.
    Boroojerdi B, Bushara KO, Corwell B, et al.: Enhanced excitability of the human visual cortex induced by short-term light deprivation. Cereb Cortex 2000, 10:529–534.PubMedCrossRefGoogle Scholar
  107. 107.
    Jeanmonod D, Magnin M, Morel A: Low-threshold calcium spike bursts in the human thalamus. Common physiopathology for sensory, motor and limbic positive symptoms. Brain 1996, 119:363–375.PubMedCrossRefGoogle Scholar
  108. 108.
    Arnulf I, Bonnet AM, Damier P, et al.: Hallucinations, REM sleep and Parkinson’s disease. Neurology 2000, 55:281–288.PubMedGoogle Scholar
  109. 109.
    Sato H, Hata Y, Hagihara K, Tsumoto T: Effects of cholinergic depletion on neuron activities in the cat visual cortex. J Neurophysiol 1987, 58:781–794.PubMedGoogle Scholar
  110. 110.
    Rodriguez R, Kallenbach U, Singer W, Munk MH: Short- and long-term effects of cholinergic modulation on gamma oscillations and response synchronization in the visual cortex. J Neurosci 2004, 24:10369–10378.PubMedCrossRefGoogle Scholar
  111. 111.
    Sherman SM: Thalamic relay functions. Prog Brain Res 2001, 134:51–69.PubMedCrossRefGoogle Scholar
  112. 112.
    Ffytche DH: Visual hallucination and illusion disorders: a clinical guide. Adv Clin Neurosci Rehab 2004, 4:16–18.Google Scholar
  113. 113.
    Merabet LB, Kobayashi M, Barton J, Pascual-Leone A: Suppression of complex visual hallucinatory experiences by occipital transcranial magnetic stimulation: a case report. Neurocase 2003, 9:436–440.PubMedCrossRefGoogle Scholar
  114. 114.
    Burke WJ, Roccaforte WH Wengel SP: Treating visual hallucinations with donepezil. Am J Psych 1999, 156:1117–1118.Google Scholar
  115. 115.
    Paulig M, Mentrup H: Charles Bonnet’s syndrome: complete remission of complex visual hallucinations treated by gabapentin. J Neurol Neurosurg Psychiatry 2001, 70:81.CrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2005

Authors and Affiliations

  • Dominic H. Ffytche
    • 1
  1. 1.Centre for Neuroimaging SciencesInstitute of PsychiatryLondonUK

Personalised recommendations